Uemura, Maiko T.
Robinson, John L.
Cousins, Katheryn A. Q.
Tropea, Thomas F.
Kargilis, Daniel C.
McBride, Jennifer D.
Suh, EunRan
Xie, Sharon X.
Xu, Yan
Porta, Sílvia
Uemura, Norihito
Van Deerlin, Vivianna M.
Wolk, David A.
Irwin, David J.
Brunden, Kurt R.
Lee, Virginia M.-Y.
Lee, Edward B.
Trojanowski, John Q. http://orcid.org/0000-0002-9239-8794
Funding for this research was provided by:
japan society for the promotion of science (201870008, 201860169)
uehara memorial foundation
alzheimer’s association research fellowship to promote diversity (AARF-D-619473)
rapid program in dementia (AARF-D-619473-RAPID)
national institute of neurological disorders and stroke (K23-NS11416-01A1, P50 NS053488)
national institute on aging (P30 AG010124, T32-AG000255, P30 AG072979, P01 AG066597, U19 AG062418)
university of pennsylvania institute on aging
lewy body dementia association
Article History
Received: 5 August 2021
Revised: 10 November 2021
Accepted: 11 November 2021
First Online: 2 December 2021
Declarations
:
: DAW reports grants from Merck, Biogen, and Avid/Eli Lilly. He has received personal fees from GE Healthcare, Functional Neuromodulation, and Neuronix. EBL and JQT are members of Acta Neuropathologica’s Editorial Board but were not involved in the editorial handling of this article.